Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (581-590 of 839) with videos related to

Pageof 84
Sort By:
European Urology|February 27, 2025
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK StudyStephen J Freedland, John P Mulhall, Martin Gleave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Standard treatments induce antigen-specific immune responses in prostate cancerNancy J Nesslinger, Robert A Sahota, Brad Stone, et al.
Translational Oncology|February 13, 2013
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease ProgressionKhalil A Choucair, Karl-Philippe Guérard, Joshua Ejdelman, et al.
Frontiers in Oncology|February 18, 2021
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer TherapeuticsVictor M Matias-Barrios, Mariia Radaeva, Yi Song, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 2013
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradationGuillaume Wettstein, Pierre-Simon Bellaye, Martin Kolb, et al.
Cancer Research|June 4, 2008
ASAP1, a gene at 8q24, is associated with prostate cancer metastasisDong Lin, Akira Watahiki, Jane Bayani, et al.
European Urology|May 20, 2014
Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted TherapiesNader Al Nakouzi, Sylvestre Le Moulec, Laurence Albigès, et al.
Cancer Cell|March 23, 2013
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activityJianfei Qi, Manisha Tripathi, Rajeev Mishra, et al.
Biomaterials|October 22, 2011
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urotheliumClement Mugabe, Peter A Raven, Ladan Fazli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancerJanessa J Laskin, Garth Nicholas, Christopher Lee, et al.
Pageof 84

Showing results (581-590 of 839) with videos related to

Sort By:
Pageof 84
European Urology|February 27, 2025
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK StudyStephen J Freedland, John P Mulhall, Martin Gleave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Standard treatments induce antigen-specific immune responses in prostate cancerNancy J Nesslinger, Robert A Sahota, Brad Stone, et al.
Translational Oncology|February 13, 2013
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease ProgressionKhalil A Choucair, Karl-Philippe Guérard, Joshua Ejdelman, et al.
Frontiers in Oncology|February 18, 2021
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer TherapeuticsVictor M Matias-Barrios, Mariia Radaeva, Yi Song, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 2013
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradationGuillaume Wettstein, Pierre-Simon Bellaye, Martin Kolb, et al.
Cancer Research|June 4, 2008
ASAP1, a gene at 8q24, is associated with prostate cancer metastasisDong Lin, Akira Watahiki, Jane Bayani, et al.
European Urology|May 20, 2014
Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted TherapiesNader Al Nakouzi, Sylvestre Le Moulec, Laurence Albigès, et al.
Cancer Cell|March 23, 2013
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activityJianfei Qi, Manisha Tripathi, Rajeev Mishra, et al.
Biomaterials|October 22, 2011
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urotheliumClement Mugabe, Peter A Raven, Ladan Fazli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancerJanessa J Laskin, Garth Nicholas, Christopher Lee, et al.
Pageof 84